Mark L. Fuerst is a freelance health and medical writer for ConsultantLive, Rheumatology Network, Psychiatric Times, and other UBM publications. He writes about rheumatology, psychiatry, neurology, endocrinology, oncology, and men’s health.
3 Common Psychiatric Disorders in Older Adults: New Insights
Are you up-to-date on the latest findings in mild cognitive impairment, dementia, and depression in elderly patients?
Lifestyle Intervention Reduces Need for Diabetes Medications
In a new study, an intensive lifestyle intervention did not markedly decrease A1c but had significant impact on need for medication.
Update on Stroke Risks
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
Migraine Risk Influenced by Extremes of Weight
Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.
Previous Asthma Exacerbations Predict Future Events in Mild, Moderate Disease
Study authors propose a new asthma patient “phenotype” in which a previous severe event is the sole predictor of another one.
Lipid Levels Linked to Inflammation in Atopic Asthma
Results of a recent study into the role of lipids in atopic asthma could help identify new targets for therapy.
Can Weight Loss in Youth Reduce Risk of Type 2 Diabetes?
New research suggests it’s possible to reverse the metabolic impact of childhood obesity and avert T2DM in adulthood.
Early Warnings of Dementia and Depression
Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.
Diabetes News Roundup: New Thoughts on Standard Thinking
Find research on diabetes patients that could shift your thinking on home blood glucose monitoring; metformin efficacy in T1DM; and race and A1c.
Update on Migraine and Parkinson Disease: 3 New Studies
New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.
By clicking Accept, you agree to become a member of the UBM Medica Community.